NEU 0.98% $19.50 neuren pharmaceuticals limited

Ann: Neuren presents at Rettsyndrome.org 2016 Research Symposium-NEU.AX, page-2

  1. 65 Posts.
    lightbulb Created with Sketch. 4
    To my layman's eye the MBA change index results are a no brainer that this has a measurable effect. From what I see the CSS change index is based on less specific indicators of efficacy than the MBA index, and I can see how they might not indicate much difference to placebo. Have a look at the list of items in the right column.

    The MBA results start returning to the placebo group at day 26 when the treatment finishes. What am I missing? Other than it was a debacle for the share price when it got knocked back, I would be inclined to assume this was a "breakthrough therapy". If my daughter was needing it I would be pretty annoyed waiting for FDA statistical analysis to catch up.
      
    If I am showing my ignorance please feel free to point out the errors!
    Cheers and good luck to all.
    rettMBA.jpg
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.50
Change
0.190(0.98%)
Mkt cap ! $2.490B
Open High Low Value Volume
$19.39 $19.98 $19.38 $7.285M 370.6K

Buyers (Bids)

No. Vol. Price($)
11 7318 $19.50
 

Sellers (Offers)

Price($) Vol. No.
$19.52 593 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
$19.55
  Change
0.190 ( 0.83 %)
Open High Low Volume
$19.41 $19.97 $19.39 83274
Last updated 15.59pm 14/06/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.